Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Jens Erik Nielsen Kudsk , Added: 2 months ago
Intracardiac echocardiography (ICE) has undergone a profound transformation in its role within left atrial appendage (LAA) closure – evolving from an experimental imaging adjunct to a clinically validated and increasingly adopted guidance strategy.In this on-demand educational discussion, Prof Jens Erik Nielsen-Kudsk (Aarhus University Hospital, DK) and Dr Sergio Berti (Fondazione Toscana G… View more
Author(s): Andrew Goldsweig Added: 7 months ago
What are the main management recommendations from SCAI and HRS concerning left atrial appendage occlusion?In this short interview, Dr Andrew Goldsweig (Baystate Medical Center, Springfield, US) discusses the new guidelines regarding transcatheter left atrial appendage occlusion by the Society for Cardiovascular Angiography & Interventions and Heart Rhythm Society. The multidisciplinary guideline… View more
Author(s): Oussama M Wazni Added: 1 year ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more
Author(s): Saibal Kar , Harriette Van Spall Added: 1 month ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more
AtriCure

Supplier

As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment… View more
Job title: Director of Electrophysiology
An industry leader in complex Electrophysiology cases and research, Dr DeLurgio uses the most advanced technology to detect, diagnose and treat arrhythmias. While some patients can be treated through the use of medication or even pacemakers, Dr DeLurgio also offers treatment through a procedure called a cardiac ablation. During this safe, minimally invasive procedure, Dr DeLurgio uses high tech… View more
Added: 1 month ago Source:  Interventional Cardiology Review Journal
For patients with atrial fibrillation (AF) at high risk for both stroke and bleeding, catheter-based left atrial appendage closure (LAAC) was not found to be non-inferior to physician-directed best medical care, according to the results of the CLOSURE-AF trial.¹MethodologyThe multicentre, randomised CLOSURE-AF trial was conducted in Germany to assess the effectiveness of LAAC compared with best… View more
Prof Sacha Salzberg was born in Geneva, Switzerland on December 5th, 1970. He studied medicine at the Free University of Brussels and graduated in July 2000. After a general surgery residency in Brussels, Belgium, Dr Salzberg joined the University Hospital in Zurich to be trained by Professor Marko Turina in Cardiac and Thoracic Vascular Surgery. During this training, he was offered a post… View more